Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Extension for Migraine Prophylaxis
NCT00210860Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in migraine, sponsored by Johnson & Johnson. Started Sep 2004; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00210860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210860.